A review of previously published articles indicates there is little evidence supporting an effective treatment of bites from bed bugs, that these insects do not appear to transmit disease, and control and eradication of bed bugs is challenging, according to an article in the April 1 issue of JAMA.
Bed bugs (Cimex lectularius) have been known as a human parasite for thousands of years, but scientific studies of this insect are recent and limited. International travel, immigration, changes in pest control practices and insecticide resistance may have contributed to a recent resurgence of this blood-sucking insect in developed countries. Bed bug infestations have been reported increasingly in homes, apartments, hotel rooms, hospitals, and dormitories in the United States since 1980, according to background information in the article. Hiding places are usually within about 3 to 6 feet of suitable hosts and include seams in mattresses, crevices in box springs, backsides of headboards, spaces under baseboards or loose wallpaper. Health consequences include biting and skin and systemic reactions. The potential for bed bugs to serve as transmitters of disease and optimal methods for bed bug pest control and eradication are unclear.
Jerome Goddard, PhD, of Mississippi State University, and Richard deShazo, MD, of the University of Mississippi Medical Center, Jackson, examined the evidence regarding the health and medical effects of bed bugs and control and eradication strategies. The researchers conducted a search for articles on these topics, identified 53 articles that met criteria for inclusion, and summarized the findings.
The authors report that although transmission of more than 40 human diseases has been attributed to bed bugs, there is little evidence that they are transporters of communicable disease. A variety of clinical reactions to bed bugs have been reported, including skin and rarely systemic reactions. A review of case reports indicated that the usual response to a bed bug bite appears to be no reaction with a barely visible mark at the location of the bite. The most common reactions for which medical attention is sought are lesions. These usually itch, and if not made worse by scratching, resolve within a week. Some patients experience complex skin reactions.
The authors write that the use of any treatment strategy for symptomatic bed bug bites has not been established. Treatments of common and complex skin reactions are usually symptomatic and not evidence based. Treatments that have been used with varying results include antibiotics, antihistamines, topical and oral corticosteroids and epinephrine (adrenaline).
The authors add that bed bugs are extremely difficult to eradicate. No evidence-based interventions to eradicate bed bugs or prevent bites were identified. Pesticide control of bed bugs is complicated by insecticide resistance, lack of effective products, and health concerns about spraying mattresses with pesticides.
“Bed bugs are likely to be more problematic in the future due to travel, immigration, and insecticide resistance,” the researchers write. “Development of effective repellents and public education about bed bugs are also important goals. Research is needed to elucidate the pathogenesis of clinical reactions to bed bug bites so that optimal therapy may be identified.”
Reference: JAMA. 2009;301[13]:1358-1366.
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.